MercoPress, en Español
Montevideo, November 5th 2024 - 07:57 UTC
Abbot Laboratiories AbbVie Inc will pay a total of US$25 million to resolve allegations that Abbott paid kickbacks to doctors in exchange for prescribing the cholesterol drug TriCor and promoted the medication for unapproved purposes.
Get our news on your inbox! Suscribe